HES2 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of HES2, a transcriptional repressor belonging to the basic helix-loop-helix (bHLH) family. HES2 plays a crucial role in regulating gene expression, particularly in pathways involved in developmental processes, including neurogenesis and cell differentiation. HES2 functions by binding to specific DNA sequences, often in promoter regions of target genes, and recruiting co-repressors to suppress gene transcription. By inhibiting HES2, these compounds disrupt its ability to silence target genes, leading to changes in the transcriptional programs that HES2 typically regulates.
The mechanism of action for HES2 inhibitors usually involves blocking the DNA-binding domain of HES2 or disrupting its interaction with co-repressors and other components of the transcriptional machinery. Some inhibitors may prevent the dimerization of HES2, a necessary step for its repressive function, while others may interfere with its ability to recognize and bind specific DNA sequences. Researchers use HES2 inhibitors to study how this transcription factor influences cellular differentiation and the regulation of developmental pathways. By inhibiting HES2, scientists can investigate the broader role of the bHLH family in controlling gene expression and how shifts in these regulatory networks impact cellular processes like proliferation, fate determination, and tissue patterning. These inhibitors are valuable tools for exploring the complex transcriptional networks involved in development and understanding the precise molecular mechanisms through which HES2 modulates gene expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could alter the methylation status of the HES2 gene, possibly affecting its expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
As an intercalating agent, it can inhibit RNA polymerase and potentially decrease HES2 mRNA synthesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that may decrease general protein synthesis, which could include the downregulation of HES2 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic translational elongation, possibly leading to a general decrease in protein levels, including HES2. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
This compound may modulate various signaling pathways and transcription factors that are involved in HES2 gene expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known for its ability to alter endosomal and lysosomal acidity, which can affect cellular processing and potentially HES2 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
It inhibits RNA polymerase II, which could lead to a decrease in the transcription of genes such as HES2. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may influence the turnover and availability of transcription factors involved in HES2 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK signaling, which may play a role in the regulation of factors that control the expression of genes like HES2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, it might downregulate the AKT/mTOR pathway, potentially impacting the synthesis of proteins such as HES2. | ||||||